Skip to content

The Hybrid Combination of CCTA and SPECT and CAG for Evaluation Prognosis of CAD: an Observational Follow-up Study

The First Affiliated Hospital of Nanjing Medical University

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04554134
Acronym
HSCA
Enrollment
550
Registered
2020-09-18
Start date
2005-01-01
Completion date
2020-02-01
Last updated
2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Disease

Keywords

SPECT, CCTA, CAG, Hybrid

Brief summary

A total of 550 patients with stable angina (40-70% stenosis) tested by coronary CT angiography (CCTA) and single photon emission computed tomography (SPECT) and coronary angiography (CAG) within 3 months were retrospectively recruited from 2005 to 2015 and follow up to 5 years. A new hybrid software was used to analysis the image data.

Interventions

None listed

Sponsors

Huai'an First People's Hospital
CollaboratorOTHER
Changzhou No.2 People's Hospital
CollaboratorOTHER
The First Affiliated Hospital with Nanjing Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Age: 18-70 2. Gender: All 3. coronary artery disease patients (CAD) 4. underwent CCTA, SPECT and coronary angiography (CAG) together within 3 months 5. Time: 2005-2015

Exclusion criteria

1. dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), congenital heart disease (CHD), atrial fibrillation (AF), ventricular tachycardia (VT) 2. Prior coronary revascularization; 3. permanent pacemaker or internal defibrillator 4. prosthetic heart valve 5. coronary image lose 6. coronary artery severe calcification 7. motion artifacts and poor CCTA image quality

Design outcomes

Primary

MeasureTime frameDescription
Major adverse cardiac events (MACE)5 YEARSAll-cause death, cardiac death, ischemic stroke, unplanned revascularization and nonfatal myocardial infarction

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026